Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / NYLI US LC R&D L
-
Total 13F shares
-
206,549
-
Share change
-
-2,283
-
Total reported value
-
$7,454,512
-
Price per share
-
$36.09
-
Number of holders
-
5
-
Value change
-
-$77,164
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) as of Q2 2025
As of 30 Jun 2025,
NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
206,549 shares.
The largest 5 holders included
NEW YORK LIFE INVESTMENT MANAGEMENT LLC, GTS SECURITIES LLC, UBS Group AG, OSAIC HOLDINGS, INC., and MORGAN STANLEY.
This page lists
5
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.